Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Artelo Biosciences, Inc. (ARTL) had Tangible Shareholders Equity of $0.82M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-9.83M |
|
-- |
|
-- |
|
$10.11M |
|
$-10.11M |
|
$0.28M |
|
$-9.83M |
|
$-10.11M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-10.11M |
|
$-10.11M |
|
$-10.11M |
|
0.54M |
|
0.54M |
|
$-18.30 |
|
$-18.30 |
|
| Balance Sheet Financials | |
$2.56M |
|
-- |
|
$2.14M |
|
$4.70M |
|
$1.77M |
|
-- |
|
$0.07M |
|
$1.84M |
|
$2.86M |
|
|
Tangible Shareholders Equity |
$0.82M |
$2.86M |
|
0.55M |
|
| Cash Flow Statement Financials | |
$-8.35M |
|
$7.77M |
|
$0.11M |
|
$2.81M |
|
$2.34M |
|
$-0.48M |
|
$0.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-343.93% |
|
-1201.22% |
|
-209.15% |
|
-343.93% |
|
$5.22 |
|
$-15.54 |
|
$-15.54 |
|